>>VIC MICOLUCCI: WORDS OF WARNING EARLIER THIS WEEK THE DEPARTMENT OF HEALTH REITERATED
ITS WARNING AGAINST THE USE OF
A DRUG CALLED IVERMECTIN
AFTER PEOPLE ACROSS THE UNITED
STATES HAVE BEEN USING IT TO
TRY AND TREAT OR EVEN PREVENT
COVID-19. THE FDA SAYS IT IS
NOT APPROVED FOR THAT USE
IT’S A DRUG THAT ACTUALLY USED
TD COWS OR HORSES. AND IT CAN
BE DANGEROUS TO PEOPLE EVEN
DEADLY. NOW ACCORDING TO THE
CDC THERE WAS A FIVEFOLD
INCREASE IN REACTIONS FROM
THAT DRUG IN THE MONTH OF JULY
THAT’S ACROSS THE COUNTRY,
LET’S LOOK HERE IN THE SUNSHINE
STATE THE FLORIDA POISON
CONTROL POSTED ON FACEBOOK
ABOUT SEEING A SPIKE IN ADVERSE
CASES RELATED TO THE DRUG.
SO FAR THEY’VE TREATED 27
PATIENTS IN THE MONTH
OF AUGUST. THEY SAY SOME OF
THESE CASES THAT THEY’VE SEEN
INVOLVED SERIOUS
SIDE EFFECTS LIKE SEIZURES
JOINING US THIS MORNING TO TALK
MORE ABOUT THE DRUG DOCTOR SHER
ROG PATEL THE ASSISTANT CHIEF
MEDICAL OFFICER WITH US HEALTH
JACKSONVILLE, GOOD MORNING TO
YOU DOCTOR.
WANT TO BE TRAVELING SO THANK
YOU IVERMECTIN HAS BEEN SENT TO
ME MANY A TIMES ON SOCIAL MEDIA
PEOPLE SAYING WHY ARE YOU
HIDING THAT THIS DRUG IS THE
CURE FOR COVID-19
WHAT’S THE MEDICAL EXPLANATION
FOR THOSE CLAIMS.
>> SO I THINK THOSE INDIVIDUALS
WHO HAVE BEEN CAMPING CHANTING
IVERMECTIN FOR COVID TREATMENT
REALLY DO SO IN THE ABSENCE OF
THAT. WELL DON CLINICAL TRIALS
WHICH SUPPORTED
TO USE AND THE VERY FEW STUDIES
THOSE INDIVIDUALS MAY REFERENCE
RECRUIT A SMALL NUMBER OF
PATIENTS. THEY’RE POOR ON
VALIDATED STUDY DESIGN AND THE
BILL SAYS ARE MUCH HIGHER ANY
OF THE APPROVED INDICATIONS FOR
IBRA WHICH ULTIMATE YOU’RE
GOING TO INCREASE YOUR RISK FOR
TOXICITY NO SIDE EFFECTS
BECAUSE OF
THOSE REASONS. THE FDA NIH THE
WORLD HEALTH ORGANIZATION AND
ACADEMIC INSTITUTIONS ACROSS
THE WORLD JUST TO US. NOT
RECOMMEND I EVER MET
FOR MANAGEMENT.
>>VIC MICOLUCCI: YET DOCTORS
ARE PRESCRIBING IT NOT ALL BUT
WE HAVE HEARD OF CASES OF OF
MEDICAL PROFESSIONALS ACTUALLY
PRESCRIBING THIS AS A TREATMENT
FOR COVID-19.
>> IF THAT’S YOU KNOW THAT’S
THAT’S I THINK A LARGE PART OF.
THAT INFORMATION THAT’S OUT
THERE.
HEALTH CARE WORKERS IN SOME
INSTANCES WE RE TRYING ANYTHING
THEY CLEAR TO HELP SOMEBODY
WHO SUFFER. MY MESSAGE FOR ALL
MY COLLEAGUES AROUND
THE COUNTRY. IF YOU’RE GOING TO
PUT A PATIENT ON SOMETHING THAT
IT’S NOT FDA AUTHORIZED
OR APPROVED. PLEASE ENSURE THAT
YOU ARE HAVING A VERY MATTER OF
FACT CONVERSATION WITH THEM
ABOUT THEIR SPECIFIC RISK
VERSUS BENEFIT. TAKING
MEDICATION IN THIS CASE TIED A
RECORD.
>>VIC MICOLUCCI: AND WHAT ARE
SOME OF THE SIDE EFFECTS THAT
WE’RE SEEING WE TALKED ABOUT
SEIZURES, WHAT ELSE COULD
HAPPEN IF YOU TAKE IVERMECTIN.
>> SOME OF THE MORE COMMON SIDE EFFECTS YOU SEE ARE PRETTY DIFFUSE RASH
ACROSS YOUR BODY YOU CAN GET IT
TO YOU IT’S FALLING UNDER ROOF,
NOTRE BASED YOUR ARM, THANKS.
YOUR FEVER MUSCLE ACHES RASH.
YOU CAN EVEN WORSE IN
EUROPE OPTION. AND IF YOU’RE
SOMEBODY WHO TAKES UP ONE THING
THEY’RE LIKE WHO WOULDN’T
YOU CAN ACTUALLY INCREASE YOUR
BLEEDING RISK BECAUSE OF A
MEDICATION LIKE IVERMECTIN
ACTUALLY MAKES OCCURRING LAST
IN YOUR SYSTEM LONGER, WHICH
MEANS IT CAN BUILD UP. AND THEN
YOU COULD BE MORE PROBABLY.
>>VIC MICOLUCCI: SO THERE IS SO
MUCH TALK ABOUT THE TREATMENT
OPTIONS AND I KNOW THAT DOCTORS
AND NURSES AND RESEARCHERS ARE
LOOKING AT ALL OF THESE RIGHT
NOW IN YOUR MEDICAL OPINION
WHAT IS THE BEST BET FOR
SOMEONE WHO IS GOING THROUGH
COVID-19.
>> COULD BE VERY MATTER OF FACT
ABOUT IT VERY
FEW EDUCATION, THE FDA IS
RECOMMENDING FOR MANAGEMENT
COVID YOU KNOW 100 EMERGENCY
USE AUTHORIZATION OR APPROVAL
IVERMECTIN IS NOT ONE.
♪
ANYBODY OUT THERE WHO IS WILLING TO APPROVE AND AUTHORIZE MEDICATION LIKE
OUR DIRECT IN YOUR BODY FOR
COVID TREATMENT. BUT YOU’RE NOT
WILLING TO GET FDA AUTHORIZED
TREATMENT LIKE A MONOCLONAL
ANTIBODY SUCH AS THE
REGENERON PRODUCT OR YOU
CONSIDER GETTING IVERMECTIN IF
YOU’VE EVER BECAME INFECTED.
BUT YOU WON’T GET A
FOUR-YEAR PROVED FDA CURRENT
VACCINE REALLY NEED TO BE
CHECKED OR
A SOURCE, YOU KNOW WE’VE GOT
SOME OPPORTUNITIES OUT THERE
FOR PROVIDERS TO PROVIDE
♪
THEIR PATIENTS WITH SOME F D A
WALKER EYES DONE.
SUCH AS MONOCLONAL ANTIBODY
REGENERON AND I THINK THAT’S
WHERE OUR FOCUS
SHOULD BE. THERE ARE OTHER
VITAMINS AND SUPPLEMENTS THAT
WERE UTILIZING BACK CAUSE MUCH
LESS FOR PATIENTS WITH MUCH LESS RISK FROM MEDICATION LIKE I CORRECT THEM AND SO ALL OF US
HEALTH CARE PROVIDERS ARE NOT
HEALTH CARE. THERE’S REALLY BE
CONSIDERING WHERE OUR SOURCES
BEFORE WE PUT THESE THINGS OUT.
>>VIC MICOLUCCI: GREAT EXPLANATIONS. THEY’RE IMPORTANT